¼Óº¸
VIP
ÅëÇÕ°Ë»ö

Çѱ¹¾àÁ¦ÇÐȸ, 2019³â ÃÑȸ ¹× ±¹Á¦Çмú´ëȸ ¼ºÈ²¸®¿¡ ¸¶ÃÄ

¸Ó´ÏÅõµ¥ÀÌ
  • âÁ¶±âȹÆÀ À̵¿¿À ±âÀÚ
  • Ä«Ä«¿ÀÅå °øÀ¯Çϱâ
  • Ä«Ä«¿ÀÅå ³ª¿¡°Ô Àü¼ÛÇϱâ
  • ÆäÀ̽ººÏ
  • Æ®À§ÅÍ
  • ³×À̹ö
  • ÅÚ·¹±×·¥
  • ¹®ÀÚ
  • 2019.11.25 17:22
  • ±ÛÀÚÅ©±âÁ¶Àý
»ç´Ü¹ýÀÎ Çѱ¹¾àÁ¦ÇÐȸ(ȸÀå À̹üÁø)´Â Áö³­ 21ÀÏ(¸ñ)~22ÀÏ(±Ý) ¾çÀÏ°£ ¼­¿ï ´õÄÉÀÌÈ£ÅÚ¿¡¼­ ¡®Dynamic Evolutions in Pharmaceutical Sciences and Technology¡¯¸¦ ÁÖÁ¦·Î ÇÑ 2019³â Çѱ¹¾àÁ¦ÇÐȸ ÃÑȸ ¹× ±¹Á¦Çмú´ëȸ¸¦ ¼ºÈ²¸®¿¡ ¸¶ÃÆ´Ù°í 25ÀÏ ¹àÇû´Ù.

»çÁøÁ¦°ø=Çѱ¹¾àÁ¦ÇÐȸ
»çÁøÁ¦°ø=Çѱ¹¾àÁ¦ÇÐȸ
À̹ø ±¹Á¦Çмú´ëȸ´Â Çѱ¹¾àÁ¦ÇÐȸ ÁÖÃÖ·Î ½ÄÇ°ÀǾàÇ°¾ÈÀüÆò°¡¿øÀÌ °øµ¿°³ÃÖÇÏ°í Çѱ¹°úÇбâ¼ú´ÜüÃÑ¿¬ÇÕȸ, Çѱ¹Á¦¾à¹ÙÀÌ¿ÀÇùȸ°¡ ÈÄ¿øÇß´Ù. ù° ³¯¿¡´Â ¹Ì±¹ KIST-Dana Farber Cancer Institute ±ÇÀÍÂù ±³¼öÀÇ ¡®Theranosis: Targeted drug delivery inspired by real-time molecular imaging¡¯À̶ó´Â ÁÖÁ¦ÀÇ ±âÁ¶°­¿¬, µÑ° ³¯¿¡´Â °è¸í´ë ¼Õµ¿È¯ ±³¼öÀÇ ¡®Pharmaceutical considerations on the poly component therapeutics from natural products¡¯¶ó´Â ÁÖÁ¦ÀÇ ±âÁ¶°­¿¬ÀÌ ÀÖ¾ú´Ù.

À̸¦ ºñ·ÔÇØ 8°³ÀÇ ÁÖÁ¦ ºÐ¾ß(¡âBiotechnology & Drug Delivery ¡âBiopharmaceutics, Pharmacokinetics & Metabolism ¡âPolymer Science & Materials ¡âRegulatory Science & Policy ¡âPhysical Pharmacy & Formulation Design ¡âDrug Design & Development ¡âPharmaceutical Quality & Analysis ¡âManufacturing Science & Engineering)¿¡ °ÉÃÄ ±¹³»»Ó¸¸ ¾Æ´Ï¶ó ¹Ì±¹, ÀϺ», Àεµ, ³×´ú¶õµå, µ§¸¶Å©, Çë°¡¸®, ½Ì°¡Æ÷¸£¿¡¼­ ÃÊûµÈ ¿¬ÀÚµé ÃÑ 34¸íÀÌ ¾àÁ¦ÇÐ ºÐ¾ßÀÇ ÃֽŠ¿¬±¸¿¡ ´ëÇØ °­¿¬Çß´Ù. ƯÈ÷ ù° ³¯ÀÇ Biotechnology & Drug Delivery(BDD) ¼¼¼ÇÀº GC³ì½ÊÀÚ, µÑ° ³¯ÀÇ Regulatory Science & Policy(RSP) ¼¼¼ÇÀº ½Ä¾àóÀÇ ÈÄ¿øÀ¸·Î ÀÌ·ïÁ³´Ù.

ÀÌ»óÀÇ Çмú°­¿¬ ¿Ü¿¡µµ Â÷¼¼´ë ¿¬±¸ÀÚ À°¼º ¹× Áö¿øÀ» À§ÇØ ¡®Preformulation considerations for biopharmaceutics blassification system¡¯À» ÁÖÁ¦·Î ÇÑ Cutting-edge techniques in solubility evaluation, Recent solidification technologies for liquid-based formulations, Challenges to improve the biopharmaceutical properties of BCS Class III/IV candidates and drug development strategy, How to prepare for a job interview & How to build a successful career¿¡ ´ëÇÑ ±³À° ÇÁ·Î±×·¥ÀÌ Ã¹Â° ³¯ ¿ÀÀü¿¡ ´ëÇпø»ýÀ» ºñ·ÔÇÑ »ê¾÷°è Âü°¡ÀÚµéÀÇ ¿­¶í È£ÀÀ ¾Æ·¡ °³ÃֵƴÙ. ¶ÇÇÑ µÑ° ³¯ ¿ÀÈÄ¿¡ °³ÃÖµÈ ¡®Young Scientist Session¡¯¿¡´Â ´ëÇпø»ý µî ÀþÀº ¿¬±¸ÀÚ°¡ Âü°¡ÇØ ±×°£ÀÇ ¿¬±¸¼º°ú¿¡ ´ëÇÑ ±¸µÎ¹ßÇ¥ÀÇ ±âȸ¸¦ °¡Á³´Ù.

±¹Á¦Çмú´ëȸ¿Í ÇÔ²² °³ÃÖµÈ ÇÐȸ ÃÑȸ¿¡¼­´Â ÆíÁý¡¤Çмú¡¤À繫À§¿øȸ º¸°í ¹× °¨»ç¼±Ãâ µî Çà»ç°¡ ÁøÇàµÆ´Ù. ¶ÇÇÑ Ã¹Â° ³¯ ¸¸Âù¿¡¼­´Â ¡âÇмú´ë»ó(°¡Å縯´ë ¿ÀÀÇö ±³¼ö) ¡â¿ì¼ö³í¹®»ó(ÃæºÏ´ë ¹Úõ¿õ ±³¼ö) ¡â»êÇбâ¼ú»ó(Áß¾Ó´ë ³ªµ¿Èñ ±³¼ö) ¡âÁ¦Á¦±â¼ú»ó(´ëÇÑ´ºÆÊ À̽ÂÈ­ °úÀå) ¡âÇõ½Å±â¼ú»ó(»ïÀ°´ë ¹ÚÁعü ±³¼ö, ÇѾç´ë ±èÁø±â ±³¼ö) ¡âÇмú¹ßÀü»ó 1(¿µ³²´ë ±èÁ¾¿À ±³¼ö, ºÎ»ê´ë À¯Áø¿í ±³¼ö, Ãæ³²´ë ¹ÚÁ¤¼÷ ±³¼ö) ¡âÇмú¹ßÀü»ó 2(¿µ³²´ë ¿ëö¼ø ±³¼ö, ¿µ³²´ë ±èÁ¾¿À ±³¼ö) ¡â»ý»ê±â¼ú°ø·Î»ó(JWÁß¿ÜÁ¦¾à ÇÑÇö¼® Àü¹«, ½Ã¹Í¾¾¿¥ÄÚ¸®¾Æ À̿ܵ¿ ´ëÇ¥, Çѱ¹¹ÙÀÌ¿ÀÄÍÁ¦¾à ¼Û¿øÈ£ ´ëÇ¥) ¡âÇ°Áú°ü¸®°ø·Î»ó(½Å½ÅÁ¦¾à ¼Û¼ö¸¸ »ó¹«) ¡â°ø·Î»ó(¼­¿ï´ë ±è´ë´ö ±³¼ö)¿¡ ´ëÇÑ ½Ã»óÀÌ ÁøÇàµÆ´Ù. µÑ° ³¯¿¡´Â Çмú´ë»óÀ» ¼ö»óÇÑ ¿ÀÀÇö ±³¼öÀÇ ¡®Rationale for a novel fixed-dose combination drug of an antiplatelet with a statin and its formulation development¡¯¿¡ ´ëÇÑ ¹ßÇ¥¿Í Á¦Á¦±â¼ú»óÀ» ¼ö»óÇÑ À̽ÂÈ­ °úÀåÀÇ ¡®Composition and preparation of cholecalciferol injection(Vita-D¢ç inj.) with improved stability by using the tocopherol¡¯¿¡ °üÇÑ °­¿¬ÀÌ ¸¹Àº °ü½É ¼Ó¿¡¼­ ÀÌ·ïÁ³´Ù.

Çѱ¹¾àÁ¦ÇÐȸ À̹üÁø ȸÀå(¾ÆÁÖ´ë ¾àÇдëÇÐ)Àº ¡°Çѱ¹¾àÁ¦ÇÐȸ´Â À̹ø ±¹Á¦Çмú´ëȸ°¡ ¾à¹° Àü´Þ ¹× °³¹ß, Á¦¾à, ±ÔÁ¦ °úÇÐ ¹× ȯÀÚ Áß½ÉÀÇ ¾à¹° Àü´Þ ¹× µðÁöÅÐ ÀÇÇÐÀ» Æ÷ÇÔÇÑ Ã·´Ü ±â¼úÁ¤º¸¸¦ Á¦°øÇÏ°í Çаè, Á¦¾à »ê¾÷ ¹× Á¤ºÎÀÇ ¿¬±¸ÀÚ¿Í Àü¹®°¡°¡ 4Â÷ »ê¾÷Çõ¸í ½Ã´ëÀÇ ÃֽŠ¿¬±¸°á°ú, »ê¾÷µ¿Çâ ¹× ±ÔÁ¦ ¾÷µ¥ÀÌÆ®¸¦ °øÀ¯ÇÏ°í ³×Æ®¿öÅ· ¹× ÇмúÀû ±³·ù ±âȸ¸¦ ¸¶·ÃÇÏ´Â °è±â°¡ µÇ¾ú±â¸¦ Èñ¸ÁÇÑ´Ù¡±°í ¸»Çß´Ù.






¸Ó´ÏÅõµ¥ÀÌ ÁÖ¿ä´º½º

"ËÝå¯ ¸Â¼³ À± ´ëÅë·É, ±â´î °Ç ±¹¹Î»Ó¡¦¹Î»ý ¿ÃÀÎÇؾß"
³×À̹ö ¸ÞÀο¡¼­ ¸Ó´ÏÅõµ¥ÀÌ ±¸µ¶ Ä«Ä«¿ÀÅå¿¡¼­ ¸Ó´ÏÅõµ¥ÀÌ Ã¤³Î Ãß°¡

º£½ºÆ®Å¬¸¯

¿À´ÃÀÇ ²ÜÆÁ

  • ´º½º ¼Ó ¿À´Ã
  • ´õ¿µ»ó
  • ³¯¾¾´Â?
  • ÇコÅõµ¥ÀÌ

¸¹ÀÌ º» ´º½º

ºÎµ¿»ê À¯Æ©ºê Á¤º¸Ã¤³Î ºÎ¸´Áö
2023 ´ëÇѹα¹ »çȸ¾ÈÀüÁö¼ö

Æ÷Åä / ¿µ»ó